Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Upstream Bio (UPB) Interest & Investment Income (2023 - 2025)

Upstream Bio (UPB) has 3 years of Interest & Investment Income data on record, last reported at $4.1 million in Q3 2025.

  • For Q3 2025, Interest & Investment Income rose 41.36% year-over-year to $4.1 million; the TTM value through Sep 2025 reached $18.4 million, up 114.28%, while the annual FY2024 figure was $12.1 million, 191.07% up from the prior year.
  • Interest & Investment Income reached $4.1 million in Q3 2025 per UPB's latest filing, down from $4.4 million in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $5.1 million in Q4 2024 and bottomed at $1.3 million in Q1 2024.
  • Average Interest & Investment Income over 3 years is $3.4 million, with a median of $3.5 million recorded in 2024.
  • The widest YoY moves for Interest & Investment Income: up 274.64% in 2025, down 41.36% in 2025.
  • A 3-year view of Interest & Investment Income shows it stood at $1.5 million in 2023, then skyrocketed by 234.17% to $5.1 million in 2024, then fell by 19.13% to $4.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Interest & Investment Income were $4.1 million in Q3 2025, $4.4 million in Q2 2025, and $4.7 million in Q1 2025.